Skip to main content
POOLBEG PHARMA PLC logo

POOLBEG PHARMA PLC — Investor Relations & Filings

Ticker · POLB ISIN · GB00BKPG7Z60 LEI · 213800UZ8WJLWYHBFL52 IL Manufacturing
Open in API
Filings indexed 161 across all filing types
Latest filing 2022-07-12 Share Issue/Capital Cha…
Country GB United Kingdom
Listing IL POLB

About POOLBEG PHARMA PLC

https://poolbegpharma.com/

Poolbeg Pharma PLC is a clinical-stage biopharmaceutical company that develops and commercializes medicines for diseases with high unmet medical needs. The company's lead asset, POLB 001, is a treatment designed to prevent Cytokine Release Syndrome (CRS), a severe side effect associated with cancer immunotherapies, with the aim of making these treatments safer and more accessible. Poolbeg is also advancing an oral GLP-1 program for obesity, offering a patient-friendly therapeutic option. The company utilizes an artificial intelligence (AI)-led discovery platform that analyzes data from human challenge trials to identify novel drug targets. This AI-driven approach aims to accelerate target identification, reduce costs, and lower development risks.

Recent filings

Filing Released Lang Actions
Price Monitoring Extension
Share Issue/Capital Change Classification · 1% confidence The document is very short (1913 characters) and its primary content is an announcement regarding a 'Price Monitoring Extension' for a security on the London Stock Exchange, referencing the RNS system. It explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' This structure—a brief notification about a market event or administrative update distributed via the RNS system—fits best under the general Regulatory Filings category, as it is not a specific financial report (like 10-K, ER, or IR) nor a specific corporate action like a dividend or management change. Given the nature of the announcement (a technical market procedure update distributed via RNS), the most appropriate classification is RNS.
2022-07-12 English
Project update for AI model of RSV data
Regulatory Filings Classification · 1% confidence The document is identified by the RNS Number (2046Q) and the header 'National Storage Mechanism', indicating it is a regulatory announcement distributed via the London Stock Exchange's RNS service. The content details an operational update regarding an AI model completion for RSV data analysis, with results expected later (Q4 2022). This is not a full financial report (like 10-K or IR), nor is it a formal earnings release (ER) or a proxy statement. Since it is a specific, non-financial operational update disseminated through the RNS system, and it doesn't fit into other specific categories like Director's Dealing (DIRS), Dividend (DIV), or Capital Change (CAP), the most appropriate classification is the general regulatory announcement category, RNS.
2022-06-27 English
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document is very short (1930 characters) and contains the header 'RNS Number : 6920P' and mentions 'RNS, the news service of the London Stock Exchange'. The content describes a 'Second Price Monitoring Extension' for a security, which is a specific, immediate operational announcement related to trading status, not a comprehensive financial report or a standard regulatory filing like 10-K or IR. Since it is a general regulatory announcement provided via the RNS service that doesn't fit into the more specific categories (like DIV, DIRS, or ER), the most appropriate classification is the general regulatory announcement fallback category, RNS.
2022-06-21 English
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document is very short (1913 characters) and contains an RNS Number (6912P) and mentions the London Stock Exchange and the Financial Conduct Authority (FCA). The content describes a 'Price Monitoring Extension' which is a specific operational announcement related to trading procedures, not a comprehensive financial report or a standard regulatory filing like 10-K or IR. Since it is a brief, specific regulatory announcement that doesn't fit the other defined categories (like DIV, DIRS, ER, etc.), it falls best under the general regulatory announcement category, RNS.
2022-06-21 English
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document is very short (1929 chars) and its primary content is an announcement regarding a 'Second Price Monitoring Extension' for a security, referencing RNS Number and the London Stock Exchange. This is a specific, non-standard regulatory announcement concerning trading mechanics, not a core financial report (like 10-K, IR, ER) or a standard corporate action (like DIV, SHA). Since it is a direct, immediate regulatory notification provided via the RNS service, and it doesn't fit into the more specific categories like DIRS, DVA, or DLST, the most appropriate classification is the general regulatory filing fallback category, RNS.
2022-05-26 English
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document is very short (1912 characters) and contains the header 'RNS Number : 9669M'. It announces a 'Price Monitoring Extension' related to trading on the London Stock Exchange. It explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' This indicates it is a general regulatory announcement that does not fit into specific financial reporting categories like 10-K, ER, or IR. Therefore, it should be classified as a general Regulatory Filing (RNS).
2022-05-26 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.